Drugs / BRV-TV
BRV-TV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00757926 | Sep 2009 → Aug 2010 | Rotavirus infection | Shantha Biotechnics Limited | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BRV-TV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00757926 ↗ |
| Known as | Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine | “Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV]” NCT00757926 ↗ |
| Modality | Vaccine | “Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine” NCT00757926 ↗ |
| Route | Oral | “Three oral doses of the vaccine (0.5 ml each)” NCT00757926 ↗ |